Merck & Co have announced that they will purchase California-based biotechnology company Prometheus Biosciences for some $10.8 billion, in a bid to enlarge its presence in the immunology field
Merck to purchase Prometheus Biosciences laosnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laosnews.net Daily Mail and Mail on Sunday newspapers.
Merck to purchase Prometheus Biosciences thailandnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailandnews.net Daily Mail and Mail on Sunday newspapers.
By Michael Erman (Reuters) - Drugmaker Merck & Co avoided billions of dollars of U.S. taxes in recent years on its top-selling cancer drug Keytruda by.